Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
4,143,303
-
Share change
-
+125,678
-
Total reported value
-
$53,319,000
-
Price per share
-
$12.90
-
Number of holders
-
19
-
Value change
-
+$2,089,366
-
Number of buys
-
9
-
Number of sells
-
8
Institutional Holders of SUMMIT THERAPEUTICS INC COM - Stock (SMMT) as of Q1 2018
As of 31 Mar 2018,
SUMMIT THERAPEUTICS INC COM - Stock (SMMT) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,143,303 shares.
The largest 10 holders included
LANSDOWNE PARTNERS (UK) LLP, Point72 Asset Management, L.P., Polar Capital LLP, AXA, MORGAN STANLEY, First Eagle Investment Management, LLC, RENAISSANCE TECHNOLOGIES LLC, Granite Point Capital Management, L.P., ACADIAN ASSET MANAGEMENT LLC, and HIGHBRIDGE CAPITAL MANAGEMENT LLC.
This page lists
19
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.